126 related articles for article (PubMed ID: 38113334)
1. RHOA drivers take alternate routes in gastric cancer.
Benton D; Chernoff J
Sci Signal; 2023 Dec; 16(816):eadk9171. PubMed ID: 38113334
[TBL] [Abstract][Full Text] [Related]
2. RHOA
Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-Function
Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
[TBL] [Abstract][Full Text] [Related]
4. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
[TBL] [Abstract][Full Text] [Related]
6. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract][Full Text] [Related]
7. A New Rho(d) Map to Diffuse Gastric Cancer.
Benton D; Chernoff J
Cancer Discov; 2020 Feb; 10(2):182-184. PubMed ID: 32024682
[TBL] [Abstract][Full Text] [Related]
8. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases.
Ushiku T; Ishikawa S; Kakiuchi M; Tanaka A; Katoh H; Aburatani H; Lauwers GY; Fukayama M
Gastric Cancer; 2016 Apr; 19(2):403-411. PubMed ID: 25823974
[TBL] [Abstract][Full Text] [Related]
9. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
[TBL] [Abstract][Full Text] [Related]
10. RhoA mutations identified in diffuse gastric cancer.
Zhou J; Hayakawa Y; Wang TC; Bass AJ
Cancer Cell; 2014 Jul; 26(1):9-11. PubMed ID: 25026207
[TBL] [Abstract][Full Text] [Related]
11. RHOA takes the RHOad less traveled to cancer.
Schaefer A; Der CJ
Trends Cancer; 2022 Aug; 8(8):655-669. PubMed ID: 35568648
[TBL] [Abstract][Full Text] [Related]
12. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L
Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739
[TBL] [Abstract][Full Text] [Related]
13. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
[TBL] [Abstract][Full Text] [Related]
14. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
[TBL] [Abstract][Full Text] [Related]
15. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
[TBL] [Abstract][Full Text] [Related]
16. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
[TBL] [Abstract][Full Text] [Related]
18. Current Study of RhoA and Associated Signaling Pathways in Gastric Cancer.
Liu H; Liu Y; Zhang X; Wang X
Curr Stem Cell Res Ther; 2020; 15(7):607-613. PubMed ID: 32223738
[TBL] [Abstract][Full Text] [Related]
19. Structure of the C-terminal guanine nucleotide exchange factor module of Trio in an autoinhibited conformation reveals its oncogenic potential.
Bandekar SJ; Arang N; Tully ES; Tang BA; Barton BL; Li S; Gutkind JS; Tesmer JJG
Sci Signal; 2019 Feb; 12(569):. PubMed ID: 30783010
[TBL] [Abstract][Full Text] [Related]
20. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
